Clinicians & therapists

Nexalin Technology has unveiled its new neurostimulation device, which aims to tackle the growing global mental health epidemic through drug-free treatment.

New UK-led research has revealed why rapid-acting antidepressants such as ketamine and psilocybin have an immediate and lasting positive effect on mood in patients with major depressive disorder (MDD). The study, led by the University of Bristol, found that psilocybin, ketamine and scopolamine can modulate affective biases associated with learning and memory. The research, published [...]

In an early new year boost for Calvert Reconnections, case managers and NHS clinicians throughout the UK have praised the centre’s “life-changing” approach to ABI rehabilitation. Following recent experience days and visits to the Keswick-based residential centre, a range of brain injury professionals have shared their thoughts. “Calvert Reconnections is an amazing place,” said Jamie [...]

The US military is to conduct research and clinical trials to determine whether cannabis and psychedelics can help treat service members with TBI and PTSD.

Video reminds of need to be mindful of inclusive communication needs this festive season

A novel drug designed to treat apathy in Parkinson's disease patients is ready to begin clinical trials.

Quibim, a company developing imaging biomarkers for precision medicine that has created AI-based software to identify early-stage neurodegenerative diseases, has announced the launch of QP-Brain

Doing so can protect mental health and guard against burnout, new study says

People aged over 65 have seen no positive developments in their mental health or social isolation, study reveals